Show simple item record

The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience

dc.contributor.authorAktan, Melih
dc.contributor.authorYenerel, Mustafa Nuri
dc.contributor.authorNalcaci, Meliha
dc.contributor.authorYildiz, Alaattin
dc.contributor.authorCaliskan, Yasar
dc.date.accessioned2021-03-03T16:42:57Z
dc.date.available2021-03-03T16:42:57Z
dc.date.issued2014
dc.identifier.citationYenerel M. N. , Aktan M., Yildiz A., Caliskan Y., Nalcaci M., "The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience", BLOOD, cilt.124, sa.21, 2014
dc.identifier.issn0006-4971
dc.identifier.othervv_1032021
dc.identifier.otherav_45c04fd8-6d55-4b28-94c3-c849fdcb09c5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/50522
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleThe Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience
dc.typeMakale
dc.relation.journalBLOOD
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume124
dc.identifier.issue21
dc.contributor.firstauthorID218492


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record